Antitrust Risks in M&A Transactions
Earlier this month, Steve Camahort, Lisl Dunlop, Mike Kennedy and I gave a CLE presentation in the Bay Area addressing the three aspects of dealing with M&A antitrust risks at the beginning of a deal:
-
Assessing the substantive risk
-
Predicting the possible reviewing agency demands for remedies
-
Allocating the antitrust risks in the purchase agreement
The deck we used is self-contained and may be viewed here.
Dale Collins
+1.212.848.412
dale.collins@shearman.com
Resources:
DOJ/FTC Horizontal Merger Guidelines (rev. Aug. 19, 2010)
DOJ/FTC Commentary on the Merger Guidelines (2006)
FTC Competition Enforcement Database
FTC Horizontal Merger Investigation Data, Fiscal Years 1996-2007
FTC Staff Statement on Negotiating Merger Remedies
FTC FAQs about Merger Consent Order Provisions
Strategic Deals Require Strategic Thinking: Antitrust Provisions to Consider in Negotiated Transactions
Examples of M&A antitrust risk-shifting provisions
Downloads:
Peter D. Lyons, Beau W. Buffier & Jessica K. Delbaum, Strategic Deals Require Strategic Thinking: Antitrust Provisions to Consider in Negotiated Transactions, M&A Lawyer, February 2010. Sample Antitrust Risk-Shifting Provisions
in M&A Transactions
Categories:
EU Mergers, US Mergers
|